Expert discussions are underway on the lifting of bans on cannabis-derived drugs in Japan. The government is set to create the environment needed to allow for the utilization of such medicines by embracing this policy in its annual “honebuto” paper,…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY CSIMC Expert Subcommittee: Reps Agree on Need to Redress Price Variations of Generics
June 13, 2013
-
BUSINESS 6 Antipsychotics in PIII Studies; Flurry of NDA Filings Expected in 2015
June 12, 2013
-
REGULATORY Expert Subcommittee to Begin Discussions on Next Year’s NHI Price Revision on June 12
June 11, 2013
-
ORGANIZATION 30% of Newly Listed Drugs in FY2012 Developed at Request of Govt: FPMAJ Survey
June 10, 2013
-
REGULATORY Japan Set to Perk Up R&D to Expand Drug Market to 9 Trillion Yen in 2020
June 7, 2013
-
BUSINESS Nichi-Iko Announces Launching of Authorized Generic of Allegra in June; Is Late Launch Part of Sanofi’s Carefully Worked-out Strategy?
June 7, 2013
-
ACADEMIA Clinical Pharmacology Network to Go Into Operation with 8 Institutions
June 6, 2013
-
REGULATORY Abe Vows to Lift Ban on Online OTC Drug Sales; MHLW to Form Panel to Verify Safety
June 6, 2013
-
BUSINESS Nippon Chemiphar to Outsource Production to Vietnam Next Spring
June 5, 2013
-
ORGANIZATION Sawai Gains Steady Market Shares of Generics in Broad Categories, Meiji Seika Pharma Strong in CNS: Survey
June 4, 2013
-
REGULATORY Study Group Fails to Reach Agreement on Online Sales of OTC Drugs; Final Report to Collate Different Views
June 4, 2013
-
REGULATORY MHLW to Look into Correlations of Pediatric Drug Intakes and Adverse Reactions
June 3, 2013
-
REGULATORY 14 APIs/26 Products Including Third Domestic Biosimilar Receive Listing
June 3, 2013
-
BUSINESS Four Pharmas Launch Filgrastim, Third Biosimilars in Japan
June 3, 2013
-
ACADEMIA Japan College of Rheumatology to Collaborate with Pfizer on PMS, Warns that Non-RA Specialists More Inclined to Prescribe Xeljanz
May 31, 2013
-
BUSINESS Astellas, Amgen Clinch Strategic Alliance on 5 Products; JV to Begin Operations in October
May 30, 2013
-
BUSINESS Ex-Novartis Employee Attended Key Panel Meetings for Diovan Trial
May 29, 2013
-
BUSINESS MTPC Files NDA for SGLT-2 Inhibitor Canagliflozin in Japan
May 29, 2013
-
REGULATORY PAFSC’s Second Committee Recommends Approval for IV Preparation of Acetaminophen
May 28, 2013
-
BUSINESS 2012 Earnings: Foreign Pharmas’ Japan Units Underperform Market Growth, Operating Profit Down 21%
May 27, 2013
ページ
“The Tesla and SpaceX CEO sent an email to employees at both companies on Tuesday saying everyone must spend 40 hours per week in the office. ‘If you don’t show up, we will assume you have resigned. The more senior…
The average ratio of females in managerial posts at Japanese drug makers has finally reached a double-digit number, at 10.0%, a Jiho survey found. However, this is still well below a near-25% ratio logged by foreign players operating in the…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…
A total of 15 new drugs (APIs) joined the NHI price list in 2021 with peak sales forecasts topping at 10 billion yen, many of them in the area of orphan diseases and with few mega launches, according to a…